An operating lease is treated like a rental contract. Neither the leased asset nor the associated liability is reported on the lessee balance sheet, but the rights may be very similar to the rights of an owner. The lessee only records the lease payments as a rental expense in income statement.

Adjustments to Financial Statements for Operating Leases
Adjusted Financial Ratios for Operating Leases (Summary)
Adjusted Total Asset Turnover
Adjusted Debt to Equity
Adjusted Return on Assets (ROA)

Gilead Sciences Inc., adjustments to financial statements

US$ in millions

	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Adjustment to Total Assets
Total assets (as reported)	59,023)	58,995)	62,125)	63,171)	67,952)
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Total assets (adjusted)	59,023)	58,995)	62,125)	63,171)	67,952)
Adjustment to Total Debt
Total debt (as reported)	24,936)	26,711)	24,987)	25,230)	26,695)
Add: Operating lease liability (before adoption of FASB Topic 842)²	—)	—)	—)	—)	—)
Add: Operating lease liabilities, current (classified as Other accrued liabilities)	102)	113)	125)	111)	101)
Add: Operating lease liabilities, noncurrent (classified as Other long-term obligations)	503)	498)	546)	467)	489)
Total debt (adjusted)	25,541)	27,322)	25,658)	25,808)	27,285)

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

^{1, 2} Equal to total present value of future operating lease payments.

Gilead Sciences Inc., Financial Data: Reported vs. Adjusted

Download chart

Gilead Sciences Inc., adjusted financial ratios

	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Asset Turnover¹
Reported total asset turnover	0.49	0.48	0.43	0.43	0.40
Adjusted total asset turnover	0.49	0.48	0.43	0.43	0.40
Debt to Equity²
Reported debt to equity	1.10	1.38	1.09	1.19	1.27
Adjusted debt to equity	1.13	1.41	1.12	1.22	1.30
Return on Assets³ (ROA)
Reported ROA	14.42%	0.81%	9.12%	7.27%	9.16%
Adjusted ROA	14.42%	0.81%	9.12%	7.27%	9.16%

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

¹ See details »

² See details »

³ See details »

Financial ratio	Description	The company
Adjusted total asset turnover	An activity ratio calculated as total revenue divided by adjusted total assets.	Gilead Sciences Inc. adjusted total asset turnover ratio improved from 2023 to 2024 and from 2024 to 2025.
Adjusted debt to equity	A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity.	Gilead Sciences Inc. adjusted debt to equity ratio deteriorated from 2023 to 2024 but then improved from 2024 to 2025 not reaching 2023 level.
Adjusted ROA	A profitability ratio calculated as net income divided by adjusted total assets.	Gilead Sciences Inc. adjusted ROA deteriorated from 2023 to 2024 but then improved from 2024 to 2025 exceeding 2023 level.

Gilead Sciences Inc., Financial Ratios: Reported vs. Adjusted

Download chart

	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Product sales	28,915)	28,610)	26,934)	26,982)	27,008)
Total assets	59,023)	58,995)	62,125)	63,171)	67,952)
Activity Ratio
Total asset turnover¹	0.49	0.48	0.43	0.43	0.40
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Product sales	28,915)	28,610)	26,934)	26,982)	27,008)
Adjusted total assets	59,023)	58,995)	62,125)	63,171)	67,952)
Activity Ratio
Adjusted total asset turnover²	0.49	0.48	0.43	0.43	0.40

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

¹ Total asset turnover = Product sales ÷ Total assets
= 28,915 ÷ 59,023 = 0.49

² Adjusted total asset turnover = Product sales ÷ Adjusted total assets
= 28,915 ÷ 59,023 = 0.49

Download chart

Activity ratio	Description	The company
Adjusted total asset turnover	An activity ratio calculated as total revenue divided by adjusted total assets.	Gilead Sciences Inc. adjusted total asset turnover ratio improved from 2023 to 2024 and from 2024 to 2025.

	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Total debt	24,936)	26,711)	24,987)	25,230)	26,695)
Total Gilead stockholders’ equity	22,703)	19,330)	22,833)	21,240)	21,069)
Solvency Ratio
Debt to equity¹	1.10	1.38	1.09	1.19	1.27
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Adjusted total debt	25,541)	27,322)	25,658)	25,808)	27,285)
Total Gilead stockholders’ equity	22,703)	19,330)	22,833)	21,240)	21,069)
Solvency Ratio
Adjusted debt to equity²	1.13	1.41	1.12	1.22	1.30

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

¹ Debt to equity = Total debt ÷ Total Gilead stockholders’ equity
= 24,936 ÷ 22,703 = 1.10

² Adjusted debt to equity = Adjusted total debt ÷ Total Gilead stockholders’ equity
= 25,541 ÷ 22,703 = 1.13

Download chart

Solvency ratio	Description	The company
Adjusted debt-to-equity	A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity.	Gilead Sciences Inc. adjusted debt-to-equity ratio deteriorated from 2023 to 2024 but then improved from 2024 to 2025 not reaching 2023 level.

	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Net income attributable to Gilead	8,510)	480)	5,665)	4,592)	6,225)
Total assets	59,023)	58,995)	62,125)	63,171)	67,952)
Profitability Ratio
ROA¹	14.42%	0.81%	9.12%	7.27%	9.16%
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Net income attributable to Gilead	8,510)	480)	5,665)	4,592)	6,225)
Adjusted total assets	59,023)	58,995)	62,125)	63,171)	67,952)
Profitability Ratio
Adjusted ROA²	14.42%	0.81%	9.12%	7.27%	9.16%

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

¹ ROA = 100 × Net income attributable to Gilead ÷ Total assets
= 100 × 8,510 ÷ 59,023 = 14.42%

² Adjusted ROA = 100 × Net income attributable to Gilead ÷ Adjusted total assets
= 100 × 8,510 ÷ 59,023 = 14.42%

Download chart

Profitability ratio	Description	The company
Adjusted ROA	A profitability ratio calculated as net income divided by adjusted total assets.	Gilead Sciences Inc. adjusted ROA deteriorated from 2023 to 2024 but then improved from 2024 to 2025 exceeding 2023 level.

Gilead Sciences Inc. (NASDAQ:GILD)

Analysis of Operating Leases

Adjustments to Financial Statements for Operating Leases

Gilead Sciences Inc., Financial Data: Reported vs. Adjusted

Adjusted Financial Ratios for Operating Leases (Summary)

Gilead Sciences Inc., Financial Ratios: Reported vs. Adjusted

Adjusted Total Asset Turnover

Adjusted Debt to Equity

Adjusted Return on Assets (ROA)